Harris Chengazi, MD
Vascular & Interventional Radiology · Williamsville, NYNPI 1861878837
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $31,550 of the $49,250 with a category attached, or 64.1%. 25 manufacturers reported payments, led by Okami Medical, Inc. at 41.7% of the total. Reporting peaked in 2023 at $27,336 and has fallen 88.6% since, to $3,120 in 2025.
Across 171 payments — averaging $288.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Okami Medical, Inc.$21K
- Argon Medical Devices, Inc.$14K
- Penumbra, Inc.$11K
- W. L. Gore & Associates, Inc.$847
- Inari Medical, Inc.$717
- Medtronic$584
- plus $2K from 19 others
What the payments were for
- Consulting fees$31,55064%
- Speaking & faculty fees$6,95014%
- Travel & lodging$3,4627%
- Food & beverage$7,28815%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Okami Medical, Inc. | 29 | $20,546 |
| Argon Medical Devices, Inc. | 8 | $13,883 |
| Penumbra, Inc. | 24 | $10,561 |
| W. L. Gore & Associates, Inc. | 25 | $847 |
| Inari Medical, Inc. | 5 | $717 |
| Medtronic | 30 | $584 |
| Sirtex Medical Inc | 11 | $514 |
| Galvanize Therapeutics, Inc | 3 | $287 |
| Boston Scientific | 6 | $278 |
| Contego Medical, Inc | 3 | $153 |
| Philips North America LLC | 2 | $148 |
| Tactile Systems Technology Inc | 1 | $114 |
| Advanced Critical Devices, Inc. | 1 | $97 |
| Imperative Care, Inc | 2 | $73 |
| Amgen | 4 | $71 |
| Bard Peripheral Vascular, Inc. | 3 | $54 |
| Stryker | 3 | $54 |
| Palette Life Sciences, Inc. | 1 | $45 |
| Siemens Medical Solutions USA, Inc. | 2 | $42 |
| Terumo Medical Corporation | 2 | $40 |
| Teleflex LLC | 1 | $35 |
| Trisalus Life Sciences, Inc. | 2 | $34 |
| Curonix LLC | 1 | $26 |
| Merit Medical Systems Inc | 1 | $24 |
| Abbott | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LOBO$19,929
- CLEANER$10,485
- Indigo System$8,396
- CLOT MGMT$2,000
- RUBY Coil$1,742
- Clot Management$1,350
- FLOWTRIEVER CATHETER, S$676
- CT THROMBECTOMY SYSTEM KIT$676
- ALIYA SYSTEM$269
- SIR-Spheres Microspheres$210
- GORE VIATORR TIPS Endoprosthesis with Controlled Expansion$144
- GENERAL - IO ABLATION$129
- (BR5) Peripheral IVUS$120
- Flexitouch Plus$114
- Entre Plus$114
- Abre$109
How this compares
$49,250 in reported general payments places this provider in the 85th percentile of 306 vascular & interventional radiology providers in New York.
See all vascular & interventional radiology providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular & interventional radiology in Williamsville
- Omar ChohanWilliamsville$54K
- Edward KimNew York$831K
- Gary SiskinAlbany$584K
- Robert LooksteinNew York$515K
- Craig GrebenManhasset$456K
- Anuj MalhotraAlbany$288K
- Rahul PatelNew York$275K
- Aaron FischmanNew York$240K
- Philip MeyersNew York$238K
- Abigail FalkNew York$214K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.